Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Clinical trial NCT05655949 · RECRUITING

Trial details

NCT number: NCT05655949
Sponsor: Beth Israel Deaconess Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Cancer Cholangiocarcinoma Cholangiocarcinoma Non-resectable Cholangiocarcinoma Metastatic Metastatic Intrahepatic Cholangiocarcinoma

Start date: 2024-02-13
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.